<?xml version='1.0' encoding='utf-8'?>
<Document xmlns="urn:iso:std:iso:20022:tech:xsd:pacs.002.001.10"><FIToFIPmtStsRpt><GrpHdr><MsgId>PACS002-ACSC-2d52ffdb</MsgId><CreDtTm>2025-10-04T11:00:00+00:00Z</CreDtTm></GrpHdr><OrgnlGrpInfAndSts><OrgnlMsgId>PAIN-2025-10-04-Euro_Pharma_SAS-8410cf19</OrgnlMsgId><OrgnlMsgNmId>pain.001.001.09</OrgnlMsgNmId><GrpSts>PART</GrpSts></OrgnlGrpInfAndSts><OrgnlPmtInfAndSts><OrgnlPmtInfId>PMTINF-2025-10-04-2b4fed</OrgnlPmtInfId><TxInfAndSts><StsId>STS-b64951b9</StsId><OrgnlInstrId>INST-20251004-00619</OrgnlInstrId><OrgnlEndToEndId>E2E-20251004-00619</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-04T11:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="GBP">137860.65</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-218d996d</StsId><OrgnlInstrId>INST-20251004-00705</OrgnlInstrId><OrgnlEndToEndId>E2E-20251004-00705</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-04T11:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="AUD">2218.84</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts><TxInfAndSts><StsId>STS-c84b9af7</StsId><OrgnlInstrId>INST-20251004-00739</OrgnlInstrId><OrgnlEndToEndId>E2E-20251004-00739</OrgnlEndToEndId><TxSts>ACSC</TxSts><AccptncDtTm>2025-10-04T11:00:00+00:00Z</AccptncDtTm><OrgnlTxRef><Amt><InstdAmt Ccy="JPY">6692.40</InstdAmt></Amt></OrgnlTxRef></TxInfAndSts></OrgnlPmtInfAndSts></FIToFIPmtStsRpt></Document>